Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: sulfa (sulfonamides) / penicillins / alcohol isopropyl attending: chief complaint: coffee ground emesis major surgical or invasive procedure: upper endoscopy history of present illness: 54 yo female with cirrhosis, hepatic encephalopathy admitted on for hepatic encephalopathy and hyponatremia. the patient was enrolled in the salt-2 trial (vasopressin antagonist v placebo). on day of admission, she was noted to have a 7 point hematocrit drop and had one episod of coffee ground emesis . she was hemodynamically stable. gi recommended urgent transfer to icu for upper endoscopy. past medical history: cirrhosis with ascites (thought to be due to methotrexate toxicity), hepatic encephalopathy, hyponatremia, portal gastropathy, psoriasis, psoriatic arthritis, multiple hand surgeries social history: denies etoh, +tobacco, 3 children family history: no history of liver or colon cancer physical exam: 99, 132/65, 114, 18, 100%ra, 58.2 kg gen: fatigued, pale, nad heent: perrla, anicteric, dry mm cv: tachy, no m/r/g, lungs: cta abd: soft, nt, +ascites, +bs, guaiaic + ext: no cyanosis or edema, + psoriatic rash involving arms, trunk neuro: a&ox3, however somnolent, +asterixis pertinent results: 09:35am blood wbc-5.6# rbc-2.75* hgb-9.5* hct-29.0* mcv-105* mch-34.5* mchc-32.8 rdw-15.7* plt ct-72* 06:20am blood wbc-6.2 rbc-2.85* hgb-9.6* hct-28.5* mcv-100* mch-33.5* mchc-33.5 rdw-18.5* plt ct-79* 09:35am blood neuts-75* bands-1 lymphs-12* monos-10 eos-1 baso-0 atyps-1* metas-0 myelos-0 09:35am blood hypochr-1+ anisocy-2+ poiklo-1+ macrocy-2+ microcy-occasional polychr-normal ovalocy-1+ target-1+ burr-1+ 09:35am blood pt-14.5* ptt-32.8 inr(pt)-1.3 09:35am blood plt smr-very low plt ct-72* 06:40am blood pt-15.9* ptt-34.5 inr(pt)-1.6 06:20am blood plt ct-79* 12:52am blood fibrino-144* 09:35am blood urean-12 creat-0.8 k-3.7 cl-100 hco3-20* 06:30am blood glucose-88 urean-15 creat-0.9 na-132* k-4.0 cl-104 hco3-21* angap-11 06:20am blood glucose-92 urean-13 creat-0.8 na-132* k-4.4 cl-104 hco3-22 angap-10 09:35am blood alt-34 ast-46* alkphos-119* totbili-2.7* 06:30am blood alt-29 ast-35 alkphos-103 totbili-2.2* 09:35am blood albumin-3.3* calcium-8.8 phos-2.7 mg-1.6 06:20am blood calcium-8.4 phos-2.9 mg-1.7 03:30pm urine color-amber appear-clear sp -1.023 03:30pm urine blood-lg nitrite-neg protein-tr glucose-neg ketone-15 bilirub-neg urobiln-neg ph-6.5 leuks-neg 03:30pm urine rbc-* wbc-0-2 bacteri-occ yeast-none epi-0-2 03:03pm ascites wbc-48* rbc-1305* polys-15* lymphs-11* monos-38* mesothe-13* macroph-21* other-2* 03:03pm ascites totpro-1.2 glucose-118 ld(ldh)-57 albumin-<1.0 micro: urine no growth serology/blood no growth fluid no growth no growth, no organisms or wbcs seen on gram stain rads: radiology chest (portable ap) no acute cardiopulmonary disease. radiology cta abd 1) cirrhotic liver, with conventional hepatic arterial anatomy, as described. small accessory right hepatic vein noted. 2) marked wall thickening within the splenic flexure and rectum, suggestive of colitis, probably inflammatory. ischemia is felt to be less likely, given the involvement of the rectum. cardiology echo the left atrium is mildly dilated. left ventricular wall thicknesses are normal. the left ventricular cavity size is normal. right ventricular chamber size and free wall motion are normal. the aortic valve leaflets (3) appear structurally normal with good leaflet excursion and no aortic regurgitation. the mitral valve appears structurally normal with trivial mitral regurgitation. there is moderate pulmonary artery systolic hypertension. there is no pericardial effusion. radiology chest (pa & lat) the heart size, mediastinal and hilar contours are normal, and the lungs appear clear. there are no pleural effusions. minimal degenerative changes are noted in the spine. radiology us abd limit, single organ limited four-quadrant ultrasound was performed to identify suitable spot for paracenteis. there is a large amount of ascites distributed throughout the abdomen. a suitable spot for paracentesis was marked in the left lower quadrant to be performed by the referring clinical team. brief hospital course: she was admitted to the icu for urgent upper endoscopy. 1. ugib: she remained hemodynamically stable and was transferred one unit of blood. she was started on iv protonix . she was also started on octreotide per hepatology team for 48 hours. egd showed >10 ulcers, no esophageal varices and portal gastropathy versus gave (gastric antral vascular ectasia). serial hematocrits and coags were tested. she was transfused one unit of prbc on with her ugib and one unit of prbc on for a slowly decreasing hematocrit. 2. cirrhosis: secondary to mtx hepatotoxicity, being followed by liver team and is to have complete liver transplant workup while inpatient, including ct abdomen. 3. hyponatremia: this is felt to be due to her cirrhosis. we continued fluid restriction. she was maintained on the salt-2 trial drug (tolvaptan vs placebo)(vasopressin antagonist). 4. mental status: initially her mental status waxed and waned. her mental status improved quickly while in the icu. we continued lactulose. paracentesis was negative for sbp. maintained on levaquin for ppx. 5. id: paracentesis was negative for sbp, however, she was started on levofloxacin for sbp prophylaxis given her increased risk for developing sbp with a ugib. 6. gi: she was made npo after the ugib. her diet was advanced slowly and she was tolerating a regualar low protein diet upon discharge. medications on admission: lactulose 30 ml tid protonix 40 mg daily aldactone 200 mg daily prochloperazine 0 mg qid prn folate 1 mg daily tolvaptan/placebo discharge medications: 1. spironolactone 100 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 2. folic acid 1 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 3. etanercept 25 mg kit sig: twenty five (25) mg injection subcutaneous twice weekly (): patient may be instructed to take more by her rheumatologist. 4. lactulose 10 g/15 ml syrup sig: forty five (45) ml po qid (4 times a day). disp:*1 bottle* refills:*2* 5. nadolol 20 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 6. pantoprazole sodium 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q12h (every 12 hours). disp:*60 tablet, delayed release (e.c.)(s)* refills:*2* 7. triamcinolone acetonide 0.1 % cream sig: one (1) appl topical tid (3 times a day). 8. tolvaptan sig: one (1) tablet qd (). discharge disposition: home with service facility: vna discharge diagnosis: hepatic encephalopathy gastric antrum vascular ectasia (gave) discharge condition: stable with no complaints, no evid of hepatic encephalopathy discharge instructions: please continue to take all medications as prescribed and to follow up with your liver doctors of this week. if you or your family members feel that you are becoming confused, or if you develop abdominal pain, chest pain, shortness of breath, dizziness or lightheadedness, please go to the nearest emergency room or call 911 to have an ambulance bring you. followup instructions: please keep all of your scheduled appointments, including with dr. (or potentially another liver fellow) this at the liver center on the of the bldg, 9am or as instructed by your liver doctors. they will try to arrange your pulmonary function tests for the same day. procedure: other endoscopy of small intestine percutaneous abdominal drainage diagnoses: alcoholic cirrhosis of liver hyposmolality and/or hyponatremia chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction hepatic encephalopathy 

Answer: The patient is high likely exposed to